Drug Design for ALK-Positive NSCLC: an Integrated Pharmacophore-Based 3D QSAR and Virtual Screening Strategy-Reference-Cited by-同舟云学术

Drug Design for ALK-Positive NSCLC: an Integrated Pharmacophore-Based 3D QSAR and Virtual Screening Strategy

Published:2017-11-13 Issue:1 Volume:185 Page:289-315
ISSN:0273-2289
Container-title:Applied Biochemistry and Biotechnology
language:en
Short-container-title:Appl Biochem Biotechnol

Author:

James Nivya,Shanthi V.,Ramanathan K.^ORCID

Funder

Science and Engineering Research Board

Publisher

Springer Science and Business Media LLC

Subject

Molecular Biology,Applied Microbiology and Biotechnology,Biochemistry,General Medicine,Bioengineering,Biotechnology

Link

http://link.springer.com/article/10.1007/s12010-017-2650-x/fulltext.html

Reference76 articles.

1. Esposito, V., Baldi, A., De Luca, A., Groger, A. M., Loda, M., Giordano, G. G., Caputi, M., Baldi, F., Pagano, M., & Giordano, A. (1997). Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer. Cancer Research, 57(16), 3381–3385.

2. Kumar, A., Shanthi, V., & Ramanathan, K. (2015). Computational investigation and experimental validation of crizotinib resistance conferred by C1156Y mutant anaplastic lymphoma kinase. Molecular Information, 34(2–3), 105–114.

3. Barreca, A., Lasorsa, E., Riera, L., Machiorlatti, R., Piva, R., Ponzoni, M., Kwee, I., Bertoni, F., Piccaluga, P. P., Pileri, S. A., & Inghirami, G. (2011). Anaplastic lymphoma kinase in human cancer. Journal of Molecular Endocrinology, 47(1), R11–R23.

4. Francesco, F., Marcello, T., Di Massimo, M., Paolo, G., Emilio, B., Giulio, R., & Silvia, N. (2016). Tackling ALK in non-small cell lung cancer: the role of novel inhibitors. Translational Lung Cancer Research, 5(3), 301–321.

5. Soda, M., Choi, Y. L., Enomoto, M., Takada, S., Yamashita, Y., Ishikawa, S., Fujiwara, S. I., Watanabe, H., Kurashina, K., Hatanaka, H., & Bando, M. (2007). Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature, 448(7153), 561.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The qualitative and quantitative analysis of Ganoderma lucidum spore powder chemical compounds as p38 MAPK inhibitors by the generation and verification of pharmacophore modelling;LWT;2024-02

2. Pharmacophore-based virtual screening, 3D QSAR, Docking, ADMET, and MD simulation studies: An in silico perspective for the identification of new potential HDAC3 inhibitors;Computers in Biology and Medicine;2023-11

3. A Graph Neural Network Model Enables Accurate Prediction of Anaplastic Lymphoma Kinase Inhibitors Compared to Other Machine Learning Models;2023 15th International Conference on Knowledge and Systems Engineering (KSE);2023-10-18

4. Identification of NS2B-NS3 Protease Inhibitors for Therapeutic Application in ZIKV Infection: A Pharmacophore-Based High-Throughput Virtual Screening and MD Simulations Approaches;Vaccines;2023-01-05

5. Comparative study between deep learning and QSAR classifications for TNBC inhibitors and novel GPCR agonist discovery;Scientific Reports;2020-10-08